Aligos Therapeutics ALGS
NASDAQ ALGS
$5.14 +0.11 (+2.22%)
As of: Oct 21, 2026 · 10:21 AM EDT

Aligos Therapeutics (ALGS) Current Leases (2019 - 2026)

Updated

Aligos Therapeutics' Current Leases was $64,000 in Q2 2026, up 68.4% from $38,000 a year earlier but down 22.0% from the prior quarter.

Analysis

Aligos Therapeutics (ALGS) Current Leases (2019 - 2026) Analysis & Trends

At the end of FY2025, Current Leases at Aligos Therapeutics came in at $145,000, up 302.8% from FY2024.

  • Current Leases shows a five-year compound annual growth rate of 17.8% (FY2020 to FY2025).
  • In earlier years, Current Leases was $36,000 in FY2024 (+260.0%), $10,000 in FY2023 (-90.7%), $108,000 in FY2022 (-21.7%) and $138,000 in FY2021 (+115.6%).
  • Quarterly Current Leases has moved between $4,000 (Q2 2024) and $145,000 (Q4 2025) over five years.
  • Compared with a year earlier, Current Leases has increased for seven straight quarters, with growth averaging 278.3% over the last eight quarters.
  • The best year-over-year quarter for Current Leases over five years was Q2 2025 (growth of 850.0%); the worst was Q1 2024 (a decline of 95.4%).
  • Per Business Quant data, ALGS's Current Leases in the three quarters before Q2 2026 was $82,000 (Q1 2026), $145,000 (Q4 2025) and $21,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,128.06 Bn 1,096.64 Bn 19.71 Bn -
2 Johnson & Johnson 615.47 Bn 534.00 Bn 17.26 Bn -
3 AbbVie 504.80 Bn 477.91 Bn 12.70 Bn -
4 Merck 368.45 Bn 322.83 Bn 12.21 Bn -
5 Novartis Ag 298.44 Bn 262.43 Bn 11.24 Bn -
6 Astrazeneca 261.92 Bn 235.60 Bn 12.86 Bn -
7 Amgen 236.10 Bn 191.50 Bn 7.24 Bn -
8 Gilead Sciences 190.71 Bn 164.91 Bn 6.22 Bn -
9 Pfizer 170.16 Bn 116.81 Bn 10.94 Bn -
10 Aligos Therapeutics 53.61 Mn -274.79 Mn - 64,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 64,000.00
Mar 31, 2026 82,000.00
Dec 31, 2025 145,000.00
Sep 30, 2025 21,000.00
Jun 30, 2025 38,000.00
Mar 31, 2025 37,000.00
Dec 31, 2024 36,000.00
Sep 30, 2024 13,000.00
Jun 30, 2024 4,000.00
Mar 31, 2024 5,000.00
Dec 31, 2023 10,000.00
Sep 30, 2023 58,000.00
Jun 30, 2023 64,000.00
Mar 31, 2023 108,000.00
Dec 31, 2022 108,000.00
Sep 30, 2022 138,000.00
Jun 30, 2022 138,000.00
Mar 31, 2022 138,000.00
Dec 31, 2021 138,000.00
Sep 30, 2021 81,000.00
API Access

Aligos Therapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=ALGS&period=max&api_key=YOUR_API_KEY